Published in Cancer Weekly, May 1st, 2006
According to recent research from Austria, "The enzyme matrix metalloproteinase-1 (MMP-1) is involved in ovarian carcinogenesis. A common guanine insertion-deletion promoter polymorphism within the gene encoding MMP-1 (MMP1) has been suggested to be a candidate gene for ovarian cancer."
"We investigated whether this common polymorphism can also serve as independent prognostic parameter in a large series of affected women. The MMPI promoter polymorphism was examined in 151 Caucasian patients with epithelial ovarian cancer using polymerase...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.